Exhibitors

Aerobe is a leading provider of cutting-edge medical technologies in neurorehabilitation, pain management, and neuroscience. Collaborating with world-renowned manufacturers, we bring the latest innovations to hospitals, research institutions, and rehabilitation centers. Our expertise spans neuroscience, sports & rehabilitation and aesthetics, ensuring healthcare professionals have access to advanced solutions that enhance patient outcomes.

As a proud partner of Medoc, a leading developer and manufacturer of neuro-diagnostic medical systems used to assess and monitor acute and chronic pain. Medoc’s Quantitative Sensory Testing (QST) Solutions are widely regarded as the “Gold-Standard” for quantitative assessment of sensory nerve fiber function. Devices are based on technologies that test and evaluate the function of small and large peripheral sensory nerve fibers – an important value-added tool for the burgeoning pain management market.

Discover how Aerobe and Medoc are transforming pain assessment at ASEAPS 2025, Singapore.

Thermal QST Provides information about the function of small diameter unmyelinated (C fibers) and thinly myelinated (A-delta fibers) nerve fibers for which no nerve conduction test, or other objective tests exist.

• TSA2 Air is the latest portable air-cooled QST device with the full range of thermal stimuli, from cool/warm sensation to cold/heat pain.
• TSA2 offers thermal stimulation in the full range from sensation to pain, heat and cold. A wide variety of thermodes is available for each body site or stimulation profile including Intraoral and Intravaginal.
• Q-Sense provides scientifically validated measures of warm, cool and heat-pain thermal sensory thresholds. All of these can be useful determinants in the evaluation of peripheral sensory nerve function, neuropathic pain, diabetic, chemotherapeutic, and other small-fiber neuropathies.

Pressure pain QST is used to measure the point at which a non-painful pressure stimulus becomes a painful sensation, assessing somatosensory function and pain sensitivity.

• AlgoMed – First software-based digital algometer to offer real-time visual & auditory feedback to control & monitor applied pressure rates to measure pressure pain threshold.

Vibratory QST uses vibration stimuli to assess the function of large sensory fibers, specifically focusing on the perception of vibration.

• VSA2 – Vibratory Sensory Analyzer offers multi-frequency, high-resolution evaluation of large sensory nerve fiber function through vibratory QST

AFT Pharmaceutical is a growing New Zealand multinational company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories worldwide. Guided by the principle of working to improve your health, we deliver medicines that make a real difference to people’s health.

Maxigesic IV®, the patented intravenous form of the Maxigesic® family of pain medicines, is a novel, dual-action, non-opioid pain reliever for use in the hospital post-operative setting or when patients cannot take medicines orally. It is a unique combination of 1000mg paracetamol and 300mg ibuprofen solution for infusion, reducing both pain and inflammation.

Avanos is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. We are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery.

We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. With corporate headquarters in Alpharetta, Georgia, Avanos operates six principal medical device production facilities, employing more than 4,000 people worldwide.

Ensuring quality is an essential part of Avanos’ business strategy, and a culture of quality is the foundation for meeting the expectations of healthcare providers and their patients. It is our policy to design, manufacture, deliver and service products that meet or exceed customer expectations for quality, performance and value.

Founded in Beijing in 2005, BNS specialises in the development, manufacture, sales and training of RF Lesion Generator for Pain Management and Neurosurgery, providing 1/2/4/8 Channels RF Lesion Generators, Disposable RF Probe and Disposable RF Cannula for the international market.
BNS RF lesion generators have been EU CE/MDA/TGA approved and currently have end users of more than 6,500 medical institutions all over the world.

Flagship Products Line:

• RF Lesion Generator;
  Indication for use: Both of Chronic Pain Management and Neuro
  Functions:
  • Impedance Monitor
  • Stimulator Monitor
  • Thermal RF
  • Pulsed RF

1. 1. 1 Channel RF Lesion Generator;
   2. 2 Channels RF Lesion Generator;
   3. 4 Channels RF Lesion Generator;
   4. 8 Channels RF Lesion Generator;
   5. Fine SS RF Electrode;
   6. Nitinol RF Electrode;
   7. Disposable RF Cannula;
   8.  Hybrid RF Electrode cannula;
   9. Coolief RF Electrode;

• 32 Channels Internal Acupuncture System;
  Indication for use: MPS (Myofascial Pain Syndrome)

1. 1. 32-A Internal Acupuncture System
   2. 32-B Internal Acupuncture System
   3. 32-C Internal Acupuncture System
   4. Fine SS Internal Acupuncture Needle
   5. Disposable Fine SS Internal Acupuncture Needle

Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, is a leading global medical device manufacturer. Founded in 1979, the company specializes in developing innovative medical solutions across various interventional medical specialties, including cardiology, neuromodulation, endoscopy, oncology, urology, and gynecology. The company operates under two main segments: Cardiovascular and MedSurg. Employing around 53,000 people globally, Boston Scientific continues to expand its market presence and drive innovation in medical technology.

In the field of pain management, Boston Scientific is advancing care by providing a robust selection of therapies to treat chronic pain. The WaveWriter Alpha™ Spinal Cord Stimulator Systems are engineered to offer profound, paresthesia-free pain relief. The Intracept™ Procedure, a minimally invasive outpatient procedure, targets vertebrogenic pain and has been shown to improve function and relieve pain long-term. Additionally, Boston Scientific’s RadioFrequency Ablation (RFA) technology is designed to interrupt pain signals at their source, providing long-lasting relief for conditions such as facet joint pain and other chronic pain conditions. These innovative solutions are designed to address multiple pain targets and change patients’ lives.

Further, in the realm of neuromodulation, Boston Scientific provides electronic implantable technologies and minimally invasive therapies to help patients manage chronic pain and neurological conditions such as movement disorders. Additionally, their Vercise Genus™ Deep Brain Stimulation (DBS) System offers precision and targeted therapy for Parkinson’s disease and essential tremor.

Boston Scientific’s neuromodulation portfolio is designed to adapt to the evolving needs of patients, offering a broad selection of evidence-based treatment options. With a strong commitment to corporate social responsibility, Boston Scientific aims to improve patient outcomes through a diverse portfolio of devices and therapies.

inomed Medizintechnik GmbH, based in Emmendingen (Germany), is a globally operating company which develops devices and systems for the protection of nerves. The company’s core competence is intraoperative neuromonitoring, where inomed is a world leader with a wide range of systems and services. Other important fields include functional neurosurgery and pain treatment. In the field of pain treatment, inomed’s range of products includes very low temperature technologies using cryo techniques (C3 CryoSystem) and high temperature RF techniques (LG Lesion Generators). The company established its pioneering technology in 1991, when it successfully introduced the first nerve monitoring system. Today, inomed German quality products monitor the safety of patients and support doctors in over 5,000 hospitals in 100 countries over the course of approximately 500,000 operations annually. Responsibility for this success lies with a team of over 400 employees spread between our headquarters, several subsidiaries and direct sales operations in 8 European countries. inomed products for direct sales are also available from trained medical equipment suppliers in more than 100 other countries.

Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and improve their lives. We strive to set the standard for quality, safety and value in the discovery, development, and manufacture of health care products, including medicines and vaccines. As one of the world’s premier innovative biopharmaceutical companies, we collaborate with stakeholders across sectors to support and expand access to reliable, affordable health care worldwide. For 175 years, we have worked to make a difference for all who rely on us. To learn more, please visit us on www.Pfizer.com.sg.

Regen Lab SA – Innovating Regenerative Medicine

Regen Lab SA is a Swiss-based company at the forefront of regenerative medicine. Since its founding in 2003, Regen Lab has become a global leader in the development and manufacturing of medical devices based on autologous blood-derived cell therapies.

Our technologies – Cellular Matrix, Plus Technology, RegenPRP™, RegenExtracell – enable the preparation of autologous biologics from the patient’s own blood, supporting tissue regeneration across a wide range of medical fields, including musculoskeletal disorders, wound care, dermatology, aesthetic medicine, urology, and gynecology.

With a strong commitment to quality and innovation, Regen Lab holds numerous patents worldwide and complies with the highest standards of medical device regulation, including CE certification and FDA clearance. All our products are manufactured in Switzerland under ISO 13485:2016 and GMP conditions.

Today, Regen Lab is present in over 80 countries, partnering with healthcare professionals around the world to provide safe, effective, and science-backed regenerative solutions.

Learn more: www.regenlab.com

Since 2003, RF Medical has been a leading manufacturer dedicated to advancing radiofrequency ablation (RFA) treatments. Our comprehensive product portfolio initially focused on tumor ablation for conditions such as liver and lung cancers, thyroid nodules, as well as treatments for varicose veins. Building on our proven radiofrequency technology, we have recently expanded our applications to include spinal care and pain management, addressing a broader spectrum of medical needs.

Building on our sophisticated radiofrequency technology and proven quality, RF Medical has expanded its presence to over 60 countries, earning a strong reputation for reliability and innovation in the global market.

As a company at the forefront of minimally invasive solutions, we are now broadening our expertise beyond radiofrequency technology. By developing and manufacturing diverse energy-based devices, such as microwave and cryoablation systems and other cutting-edge modalities, we are continuously expanding our applications to address a wider range of medical needs.

With an unwavering commitment to creating a healthier world, RF Medical invests extensively in research and development, striving to provide advanced solutions that empower healthcare professionals and improve patient outcomes.

In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life.

Viatris’ name is rooted in Latin and embodies a vision of providing a path (“VIA”) to three (“TRIS”) critical goals: expanding access to medicines, leading by innovating to meet patient needs, and being a trusted partner for the healthcare community worldwide.

We produce medicines for patients across a broad range of major therapeutic areas, spanning both noncommunicable and infectious diseases.

We provide access to our of high-quality medicines in more than 165 countries and territories.